Avecho Biotechnology Limited (AVE) develops and commercialises innovative Human and Animal Health products using its proprietary drug delivery system called TPM (Tocopherol Phosphate Mixture). TPM is derived from Vitamin E using unique, proprietary and patented processes and is proven to enhance the solubility and oral, dermal and transdermal absorption of drugs and nutrients. Major projects include delivering TPM enhanced injectable, oral and topical products for the human health market, including the recently announced application of TPM to cannabinoids.